Surveillance and treatment of primary hepatocellular carcinoma (aka. STOP HCC): protocol for a prospective cohort study of high-risk patients for HCC using GALAD-score
Abstract Background Vietnam and Saudi Arabia have high disease burden of primary hepatocellular carcinoma (HCC). Early detection in asymptomatic patients at risk for HCC is a strategy to improve survival outcomes in HCC management. GALAD score, a serum-based panel, has demonstrated promising clinica...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMC
2023-09-01
|
| Серии: | BMC Cancer |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1186/s12885-023-11167-9 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
